Cargando…

Integrated algorithm combining plasma biomarkers and cognitive assessments accurately predicts brain β-amyloid pathology

BACKGROUND: Accurate prediction of cerebral amyloidosis with easily available indicators is urgently needed for diagnosis and treatment of Alzheimer’s disease (AD). METHODS: We examined plasma Aβ42, Aβ40, T-tau, P-tau181, and NfL, with APOE genotypes, cognitive test scores and key demographics in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Fengfeng, Huang, Yanlu, Cai, Xiao, Wang, Ying, Guan, Yihui, Deng, Jiale, Yang, Dake, Zhu, Jinhang, Zhao, Yike, Xie, Fang, Fang, Zhuo, Guo, Qihao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172320/ https://www.ncbi.nlm.nih.gov/pubmed/37165172 http://dx.doi.org/10.1038/s43856-023-00295-9

Ejemplares similares

Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer’s disease
por: Wang, Yifan, et al.
Publicado: (2022)

Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients
por: Huang, Yanlu, et al.
Publicado: (2022)

Independent study demonstrates amyloid probability score accurately indicates amyloid pathology
por: Fogelman, Ilana, et al.
Publicado: (2023)

Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years
por: den Braber, Anouk, et al.
Publicado: (2023)

Protocol for a diagnostic accuracy study to develop diagnosis algorithm for biliary atresia using MMP-7 (DIABA-7 study): a study recruiting from Chinese Biliary Atresia Collaborative Network
por: Jiang, Jingying, et al.
Publicado: (2021)

The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
por: Pan, Fengfeng, et al.
Publicado: (2023)

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
por: Wang, Pei‐Ning, et al.
Publicado: (2020)

Correlation Between Urine Formaldehyde and Cognitive Abilities in the Clinical Spectrum of Alzheimer’s Disease
por: Wang, Ying, et al.
Publicado: (2022)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
por: Li, QinJie, et al.
Publicado: (2022)

Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers
por: Chen, Ting-Bin, et al.
Publicado: (2021)

Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
por: Verberk, Inge M. W., et al.
Publicado: (2018)

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K, et al.
Publicado: (2017)

The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Ling-Yun, et al.
Publicado: (2018)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K., et al.
Publicado: (2018)

Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer’s Continuum
por: Pan, Feng-Feng, et al.
Publicado: (2022)

Novel plasma biomarker surrogating cerebral amyloid deposition
por: KANEKO, Naoki, et al.
Publicado: (2014)

Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment
por: Huang, Yanlu, et al.
Publicado: (2022)

Amyloid‐beta plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive dysfunction syndrome
por: Stylianaki, Ioanna, et al.
Publicado: (2020)

Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology
por: Kim, Keun You, et al.
Publicado: (2022)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid Angiopathy
por: Foidl, Bettina M., et al.
Publicado: (2020)

The accuracy and robustness of plasma biomarker models for amyloid PET positivity
por: Benedet, Andréa L., et al.
Publicado: (2022)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Identification and verification of plasma protein biomarkers that accurately identify an ectopic pregnancy
por: Beer, Lynn A., et al.
Publicado: (2023)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

Editorial: Biomarker Detection Algorithms and Tools for Medical Imaging or Omics Data
por: Cho, William C., et al.
Publicado: (2022)

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer’s Disease
por: Gentreau, Mélissa, et al.
Publicado: (2022)

Zoo: Selecting Transcriptomic and Methylomic Biomarkers by Ensembling Animal-Inspired Swarm Intelligence Feature Selection Algorithms
por: Han, Yuanyuan, et al.
Publicado: (2021)

Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia
por: Lee, Seung Mi, et al.
Publicado: (2020)

A highly accurate heuristic algorithm for the haplotype assembly problem
por: Deng, Fei, et al.
Publicado: (2013)

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
por: Kim, Keun You, et al.
Publicado: (2022)

Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
por: Toledo, Jon B, et al.
Publicado: (2013)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
por: Startin, Carla M., et al.
Publicado: (2019)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers
por: Tosun, Duygu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eikss2f2f2fnhuetv342rvl98u